J Rauh, MD
Obstetrics & Gynecology · Miles City, MTNPI 1649378530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 45.6% of the total. Reporting peaked in 2019 at $399 and has fallen 70.7% since, to $117 in 2025.
Across 78 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$657
- Lilly USA, LLC$222
- Novo Nordisk$150
- Corcept Therapeutics$136
- Pfizer$99
- Amgen$82
- plus $96 from 4 others
What the payments were for
- Food & beverage$1,435100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $657 |
| Lilly USA, LLC | 13 | $222 |
| Novo Nordisk | 9 | $150 |
| Corcept Therapeutics | 8 | $136 |
| Pfizer | 7 | $99 |
| Amgen | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| AbbVie | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $11 |
How this compares
$1,441 in reported general payments places this provider in the 65th percentile of 95 obstetrics & gynecology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 175 | $223,798 |
| MounjaroTirzepatide | 143 | $153,552 |
| FarxigaDapagliflozin Propanediol | 59 | $45,192 |
| TrulicityDulaglutide | 45 | $39,228 |
| Repatha SureclickEvolocumab | 67 | $37,890 |
| EliquisApixaban | 48 | $27,780 |
| JardianceEmpagliflozin | 37 | $21,713 |
| Emgality PenGalcanezumab-Gnlm | 16 | $16,344 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 24 | $14,812 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,986 |
| PremarinEstrogens, Conjugated | 20 | $6,906 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $5,621 |
| Levetiracetam | 38 | $5,150 |
| Potassium Chloride | 67 | $3,359 |
| Estradiol | 134 | $2,977 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $150 | $224,568186 claims |
| Lilly USA, LLCMounjaro, Trulicity, Olanzapine | $222 | $193,953224 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $657 | $55,17874 claims |
| PfizerEliquis, Premarin | $99 | $34,68668 claims |
| AbbVieSynthroid | $25 | $1,75219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 95 obstetrics & gynecology providers in Montana.
Other obstetrics & gynecology in Miles City
- Jay LittlefieldMiles City$999
- Jeffery WilliamsMiles City$356
- Alexis O'LearyHelena$11K
- Silddy AtilanoBozeman$11K
- Jessica ParsonHelena$11K
- Toby MarshallHavre$9K
- Tessa WintertonWhitefish$9K
- Shaun GillisBozeman$9K
- Mary CamdenHamilton$8K
- Alyson RighettiLivingston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.